Grail's Slump Enters Week: Navigating Biotech's Setback
Grail's stock has slid as its Galleri MCED test faced a major trial setback. This piece breaks down what happened, wh...
Discover why indices rise or fall, examining earnings, macro data, and policy factors that shape broad market direction.
21,369 articlesGrail's stock has slid as its Galleri MCED test faced a major trial setback. This piece breaks down what happened, wh...
A landmark, independent study finds racial disparities in AI-driven hiring tools used by major employers, affecting B...
In late May 2026, a 62-year-old engineer with $1.4 in retirement assets begins tapping his 401(K) ahead of Social Sec...
Doximity sits at a crossroads: a robust physician network with multiple monetization channels, yet facing disruption ...
Zillow filed an antitrust suit against MRED and Compass, raising the question of whether a real estate data platform ...
A mother documents her autistic daughter's journey and discovers that one teen’s message made a lasting impact. The s...
Today’s stock market today mood shifted as Hewlett Packard Enterprise climbed on the back of Dell’s AI server enthusi...
Retirees with seven-figure 401(k) balances face rising RMD pressures. A new, streamlined Roth conversion path is gain...
As Micron prepares to report on June 24, investors buzz about a potential stock surge. This guide breaks down catalys...
A single indicator could steer the next 12 months for the iShares 20+ Year Treasury Bond ETF (TLT). If the 30-year yi...
Ripple expands its RLUSD stablecoin into Turkey, backing a push for institutional, regulation-friendly digital dollar...
Ethereum faces another wave of selling pressure as macro tensions, on-chain signals, and sentiment converge. This gui...